Bathing Additives in Pediatric Atopic Dermatitis

Dermatitis, Atopic Clinical Trial

Official title:

Bathing Additives in Management of Pediatric Atopic Dermatitis

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02582788
• Other study ID #: 15-003161
• Status: Terminated
• Phase: N/A
• Start date: October 2015
• Est. completion date: April 2018

Study information

• Verified date: August 2018
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The current clinical guidelines for management of atopic dermatitis now recommend bleach baths. This requires simply the addition of regular household bleach to twice-weekly baths. At the Mayo Clinic, dilute acetic acid (vinegar) has been recommended for decades in wet wraps to treat patients hospitalized for their atopic dermatitis. However, this practice has not been widely adopted in the pediatric dermatology community. Will the use of dilute acetic acid (vinegar) in twice weekly baths help manage atopic dermatitis in pediatric patients as well as, or better than, the current accepted guidelines?

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 10
• Est. completion date: April 2018
• Est. primary completion date: April 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Months to 17 Years

Eligibility

Inclusion Criteria:

1. Patients from 6 months to 17 years of age

2. Currently residing in US.

3. Follow up visits at 1 month, 3 months and 6 months after initiation of treatment in study (Figure 1).

4. Last follow-up at 1 year in clinic or via written mailed-out survey.

5. Diagnosis of atopic dermatitis AND

1. Have active signs of bacterial skin infection OR

2. Any documented suspected history of bacterial skin infection (weeping, crusting, and/or pustules on exam), OR

3. Prescription for oral antibiotics for skin infection in the past 6 months from any provider). OR

4. Have been prescribed bleach baths as part of an atopic dermatitis skin care regimen.

Exclusion Criteria:

1. Superficial skin infection without diagnosis of atopic dermatitis

2. Lack of in-clinic follow up assessment at 6 months

Related Conditions & MeSH terms

• Dermatitis
• Dermatitis, Atopic
• Eczema

Intervention

Other:
• Bathing Additive

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	EASI score at 6 months		6 months
Secondary	Courses of antibiotics required		1 year